Yu, T.-C. and Chou, W.-C. (2026) “Challenges of Hepatitis B Virus Reactivation and CD19 Testing Following Tafasitamab Plus Lenalidomide for Relapsed Diffuse Large B-Cell Lymphoma”, Journal of Medical Cases, 17(5), pp. 231–237. doi:10.14740/jmc5313.